Search Results - "Miller, Carl W."

Refine Results
  1. 1
  2. 2

    Epigenetic Silencing of the Candidate Tumor Suppressor Gene Per1 in Non–Small Cell Lung Cancer by GERY, Sigal, KOMATSU, Naoki, KAWAMATA, Norihiko, MILLER, Carl W, DESMOND, Julian, VIRK, Renu K, MARCHEVSKY, Alberto, MCKENNA, Robert, TAGUCHI, Hirokuni, KOEFFLER, H. Phillip

    Published in Clinical cancer research (01-03-2007)
    “…Purpose: Epigenetic events are a critical factor contributing to cancer development. The purpose of this study was to identify tumor suppressor genes silenced…”
    Get full text
    Journal Article
  3. 3

    FOXA1: Growth inhibitor and a favorable prognostic factor in human breast cancer by Wolf, Ido, Bose, Shikha, Williamson, Elizabeth A., Miller, Carl W., Karlan, Beth Y., Koeffler, H. Phillip

    Published in International journal of cancer (01-03-2007)
    “…The transcription factor Forkhead‐box A1 (Foxa1), a member of the FOX class of transcription factors, has been implicated in the pathogenesis of lung,…”
    Get full text
    Journal Article
  4. 4

    ERCC5 Is a Novel Biomarker of Ovarian Cancer Prognosis by WALSH, Christine S, OGAWA, Seishi, SANADA, Masashi, NANNYA, Yasuhito, SLAMON, Dennis J, KOEFFLER, H. Phillip, KARLAN, Beth Y, KARAHASHI, Hisae, SCALES, Daniel R, PAVELKA, James C, TRAN, Hang, MILLER, Carl W, KAWAMATA, Norihiko, GINTHER, Charles, DERING, Judy

    Published in Journal of clinical oncology (20-06-2008)
    “…To identify a biomarker of ovarian cancer response to chemotherapy. PATIENTS AND METHODS Study: participants had epithelial ovarian cancer treated with surgery…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Frequent genomic abnormalities in acute myeloid leukemia/myelodysplastic syndrome with normal karyotype by AKAGI, Tadayuki, OGAWA, Seishi, HAFERLACH, Torsten, HAFERLACH, Claudia, KOEFFLER, H. Phillip, DUGAS, Martin, KAWAMATA, Norihiko, YAMAMOTO, Go, NANNYA, Yasuhito, SANADA, Masashi, MILLER, Carl W, YUNG, Amanda, SCHNITTGER, Susanne

    Published in Haematologica (Roma) (01-02-2009)
    “…Acute myeloid leukemia is a clonal hematopoietic malignant disease; about 45-50% of cases do not have detectable chromosomal abnormalities. Here, we identified…”
    Get full text
    Journal Article
  7. 7

    Association between a functional single nucleotide polymorphism in the MDM2 gene and sporadic endometrial cancer risk by Walsh, Christine S, Miller, Carl W, Karlan, Beth Y, Koeffler, H. Phillip

    Published in Gynecologic oncology (01-03-2007)
    “…Abstract Objectives. MDM2 is an important negative regulator of the p53 tumor suppressor protein. A naturally occurring T/G single nucleotide polymorphism…”
    Get full text
    Journal Article
  8. 8

    Genome-Wide Loss of Heterozygosity and Uniparental Disomy in BRCA1/2-Associated Ovarian Carcinomas by WALSH, Christine S, OGAWA, Seishi, SCOLES, Daniel R, MILLER, Carl W, KAWAMATA, Norihiko, NAROD, Steven A, KOEFFLER, H. Phillip, KARLAN, Beth Y

    Published in Clinical cancer research (01-12-2008)
    “…Purpose: The importance of the BRCA gene products in maintaining genomic stability led us to hypothesize that BRCA-associated and sporadic ovarian cancers…”
    Get full text
    Journal Article
  9. 9

    Sociodemographic and health-related determinants of breast and cervical cancer screening behavior, 2005 by Welch, Cindy, Miller, Carl W, James, Nadine T

    “…To identify sociodemographic and health-related determinants of Breast and Cervical Cancer Screening behaviors and evaluate progress toward Healthy People 2010…”
    Get more information
    Journal Article
  10. 10

    Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors by Miller, Carl W., Ikezoe, Takayuki, Krug, Utz, Hofmann, Wolf-K., Tavor, Sigal, Vegesna, Vijaya, Tsukasaki, Kunihiro, Takeuchi, Seisho, Koeffler, H. Phillip

    Published in Genes chromosomes & cancer (01-01-2002)
    “…Checkpoint genes, activated in response to DNA damage and other stresses, are frequently targeted for alteration in cancer. Checkpoint kinase 2 (CHK2, CDS1,…”
    Get full text
    Journal Article
  11. 11

    Functional analysis of a novel DNA polymorphism of a tandem repeated sequence in the asparagine synthetase gene in acute lymphoblastic leukemia cells by Akagi, Tadayuki, Yin, Dong, Kawamata, Norihiko, Bartram, Claus R, Hofmann, Wolf-K, Song, Jee Hoon, Miller, Carl W, den Boer, Monique L, Koeffler, H. Phillip

    Published in Leukemia research (01-07-2009)
    “…Abstract Asparagine synthetase (ASNS) is an enzyme expressed ubiquitously in mammalian cells. Here, we discovered two 14-bp tandem repeat (2R, wild-type)…”
    Get full text
    Journal Article
  12. 12

    Cyr61 Suppresses Growth of Human Endometrial Cancer Cells by Chien, Wenwen, Kumagai, Takashi, Miller, Carl W., Desmond, Julian C., Frank, Jonathan M., Said, Jonathan W., Koeffler, H. Phillip

    Published in The Journal of biological chemistry (17-12-2004)
    “…Cyr61 (CCN1) is a member of the CCN protein family; these secreted proteins are involved in diverse biological processes such as cell adhesion, angiogenesis,…”
    Get full text
    Journal Article
  13. 13

    Xeroderma pigmentosum complementation group C single‐nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression‐free survival in advanced ovarian cancer by Fleming, Nicole D., Agadjanian, Hasmik, Nassanian, Hoorig, Miller, Carl W., Orsulic, Sandra, Karlan, Beth Y., Walsh, Christine S.

    Published in Cancer (01-02-2012)
    “…BACKGROUND: The nucleotide excision repair (NER) pathway is the principal DNA repair pathway for removing bulky platinum DNA adducts. Suboptimal DNA repair may…”
    Get full text
    Journal Article
  14. 14

    Health status, physical disability, and obesity among adult Mississippians with chronic joint symptoms or doctor-diagnosed arthritis: findings from the Behavioral Risk Factor Surveillance System, 2003 by James, Nadine T, Miller, Carl W, Fos, Peter J, Zhang, Lei, Wall, Peggy, Welch, Cindy

    Published in Preventing chronic disease (01-07-2008)
    “…The purpose of this study was to analyze 2003 Mississippi Behavioral Risk Factor Surveillance System (BRFSS) data to describe the health of Mississippians with…”
    Get full text
    Journal Article
  15. 15

    Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias by Hofmann, Wolf-K., Miller, Carl W., Tsukasaki, Kunihiro, Tavor, Sigal, Ikezoe, Takayuki, Hoelzer, Dieter, Takeuchi, Seisho, Koeffler, H.Phillip

    Published in Leukemia research (01-04-2001)
    “…Checkpoint genes code for a family of proteins which sense DNA damage in eukaryotic cells. They play an important role in the control of the cell cycle. The…”
    Get full text
    Journal Article
  16. 16

    Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations by Akagi, Tadayuki, Shih, Lee-Yung, Kato, Motohiro, Kawamata, Norihiko, Yamamoto, Go, Sanada, Masashi, Okamoto, Ryoko, Miller, Carl W., Liang, Der-Cherng, Ogawa, Seishi, Koeffler, H. Phillip

    Published in Blood (19-02-2009)
    “…Acute promyelocytic leukemia (APL) is a hematopoietic malignant disease characterized by the chromosomal translocation t(15;17), resulting in the formation of…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein α in myelodysplastic syndromes and acute myeloid leukemias by Gombart, Adrian F., Hofmann, Wolf-K., Kawano, Seiji, Takeuchi, Seisho, Krug, Utz, Kwok, Scott H., Larsen, Renee J., Asou, Hiroya, Miller, Carl W., Hoelzer, Dieter, Koeffler, H. Phillip

    Published in Blood (15-02-2002)
    “…The CCAAT/enhancer binding protein α (C/EBPα) protein is essential for proper lung and liver function and granulocytic and adipose tissue differentation. It…”
    Get full text
    Journal Article
  19. 19

    Absence of R24C mutation of the CDK4 gene in leukemias and solid tumors by MORI, Naoki, RONG YANG, KAWAMATA, Norihiko, MILLER, Carl W, MIZOGUCHI, Hideaki, KOEFFLER, H. Phillip

    Published in International journal of hematology (01-04-2003)
    “…A mutation of the p16(INK4a)-binding domain of the cyclin dependent kinase 4 (CDK4) gene, R24C, has been reported in some cases of melanoma. This mutation…”
    Get full text
    Journal Article
  20. 20

    Genetic profiling of myeloproliferative disorders by single-nucleotide polymorphism oligonucleotide microarray by Kawamata, Norihiko, Ogawa, Seishi, Yamamoto, Go, Lehmann, Soren, Levine, Ross L, Pikman, Yana, Nannya, Yasuhito, Sanada, Masashi, Miller, Carl W, Gilliland, D. Gary, Koeffler, H. Phillip

    Published in Experimental hematology (01-11-2008)
    “…Objective Myeloproliferative disorders (MPD) are clonal hematopoietic diseases that include polycythemia vera (PV), essential thrombocytosis (ET), and primary…”
    Get full text
    Journal Article